The award is presented annually to the ASGCT member who has achieved pioneering research success and a lifetime of significant contributions to the field of gene and cell therapy. It is the society’s highest honor.
Rossi is widely regarded as a world leader in the development of RNA interference and in clinical research involving nucleic acids for the treatment of various diseases. Currently, he is focusing on enhancing the intracellular efficacy of ribozymes, small RNAs and siRNAi, and their application to gene therapy for HIV and cancer.
Rossi is widely regarded as a world leader in the development of RNA interference and in clinical research involving nucleic acids for the treatment of various diseases. Currently, he is focusing on enhancing the intracellular efficacy of ribozymes, small RNAs and siRNAi, and their application to gene therapy for HIV and cancer.
Rossi is the editor in chief of Molecular Therapy-Nucleic Acids and deputy editor of Molecular Therapy. He has authored more than 275 peer-reviewed papers and more than 70 book chapters. Rossi is also founding president of Oligonucleotide Therapeutics Society.
Rossi accepted ASGCT’s Outstanding Achievement Award at the Society’s annual meeting in Washington, D.C.
Rossi accepted ASGCT’s Outstanding Achievement Award at the Society’s annual meeting in Washington, D.C.
****